Skip to main content
. Author manuscript; available in PMC: 2011 Mar 30.
Published in final edited form as: BJU Int. 2008 Mar 13;101(12):1503–1506. doi: 10.1111/j.1464-410X.2008.07500.x

TABLE 1.

The clinical and pathological features of the patients, stratified by age decade

Age, years

Variable 30–39 40–49 50–59 60–69 ≥70
Preoperative PSA level, ng/mL
 Mean (SD) 6.8 (10.7) 6.9 (6.7) 7.3 (5.9) 7.9 (7.4) 8.8 (7.6)
 Median (range) 4.0 (0.3–66) 5.4 (0.2–79) 5.8 (0.1–68) 6.2 (0.1–151) 7.0 (0.7–49.9)
n (%):
Biopsy Gleason score
 ≤6 36 (85.7) 744 (84.3) 3242 (79.8) 2757 (74) 126 (70.4)
 7 4 (9.5) 123 (13.9) 697 (17.2) 798 (21.5) 40 (22.3)
 8–10 2 (4.8) 16 (1.8) 123 (3.0) 166 (4.5) 13 (7.3)
Clinical stage
 ≤T1c 26 (61.9) 523 (58.8) 2543 (62.3) 2202 (58.7) 95 (53.7)
 T2 16 (38.1) 353 (39.7) 1492 (36.6) 1517 (40.4) 82 (46.3)
 T3 0 13 (1.5) 44 (1.1) 30 (0.8) 0
 D0 0 0 0 2 (0.1) 0
Organ-confined 34 (81.0) 616 (69.1) 2654 (65.2) 2133 (56.8) 90 (49.7)
Positive surgical margins 2 (4.8) 100 (11.2) 536 (13.1) 607 (16.1) 38 (20.9)
Capsular penetration 8 (19.1) 272 (30.5) 1386 (33.9) 1587 (42.1) 87 (47.8)
Seminal vesicle invasion 1 (2.4) 43 (4.8) 224 (5.5) 274 (7.3) 21 (11.6)
Lymph node metastases 1 (2.4) 32 (3.6) 124 (3.0) 146 (3.9) 8 (4.4)